To evaluate a potential predictive value of FOXM1 mRNA levels in patient-derived ALL samples at the time of diagnosis, we conducted a retrospective analysis of FOXM1 expression. This evidence concerns the gene FOXM1 and acute lymphoblastic leukemia.